HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pierre Oudet Selected Research

Adenocarcinoma

6/2003Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pierre Oudet Research Topics

Disease

6Neoplasms (Cancer)
02/2012 - 06/2003
3Osteosarcoma (Osteogenic Sarcoma)
08/2007 - 04/2005
3Carcinogenesis
05/2007 - 11/2002
2Hypoxia (Hypoxemia)
02/2012 - 02/2009
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2008 - 06/2003
2Sepsis (Septicemia)
01/2007 - 03/2004
1Septic Shock (Toxic Shock Syndrome)
01/2010
1Inflammation (Inflammations)
01/2010
1Colonic Neoplasms (Colon Cancer)
02/2009
1Multiple Organ Failure (MODS)
01/2007
1Kidney Neoplasms (Kidney Cancer)
09/2006
1Chromosome Aberrations (Chromosome Abnormalities)
11/2005
1Critical Illness (Critically Ill)
03/2004
1Fever (Fevers)
03/2004
1Infections
03/2004
1Carcinoma (Carcinomatosis)
09/2003
1Lung Neoplasms (Lung Cancer)
06/2003
1Adenocarcinoma
06/2003
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2003
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2003
1Disease Progression
06/2003
1Adenocarcinoma of Lung
10/2002

Drug/Important Bio-Agent (IBA)

4DNA (Deoxyribonucleic Acid)IBA
02/2012 - 06/2003
2Proteins (Proteins, Gene)FDA Link
02/2012 - 08/2007
2Irinotecan (Camptosar)FDA LinkGeneric
02/2012 - 02/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2010 - 03/2004
2Interleukin-10 (Interleukin 10)IBA
01/2010 - 03/2004
2CytokinesIBA
01/2010 - 03/2004
2Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
06/2007 - 04/2005
2Biological ProductsIBA
05/2007 - 04/2005
2Messenger RNA (mRNA)IBA
05/2007 - 09/2003
1Type I DNA Topoisomerases (Topoisomerase I)IBA
02/2012
1Interferon-gamma (Interferon, gamma)IBA
01/2010
1Sirolimus (Rapamycin)FDA Link
02/2009
1Transcription Factors (Transcription Factor)IBA
02/2009
1TOR Serine-Threonine KinasesIBA
02/2009
1Tyrosine Kinase InhibitorsIBA
04/2008
1Epidermal Growth Factor (EGF)IBA
04/2008
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
04/2008
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2008
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
08/2007
1Therapeutic UsesIBA
06/2007
1ProteomeIBA
05/2007
1L 644711 (B-3(+))IBA
05/2007
1Protein CIBA
01/2007
1AnticoagulantsIBA
01/2007
1ParaffinIBA
04/2005
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
04/2005
1RNA (Ribonucleic Acid)IBA
03/2004
1Interleukin-6 (Interleukin 6)IBA
03/2004
1C-Reactive ProteinIBA
03/2004
1Annexin A5IBA
03/2004
1Type II DNA Topoisomerases (Topoisomerase II)IBA
11/2002
1Transforming Growth Factor beta (TGF-beta)IBA
10/2002
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
10/2002

Therapy/Procedure

3Therapeutics
02/2009 - 03/2004
1Combination Drug Therapy (Combination Chemotherapy)
02/2009
1Critical Care (Surgical Intensive Care)
03/2004